Advertisement

Topics

Researchers at Albert Einstein College of Medicine receive $2.6 million NIH grant to develop targeted cancer immunotherapies

20:00 EDT 18 Oct 2016 | AAAS

(Albert Einstein College of Medicine) Researchers, led by Steven Almo, Ph.D., and Chandan Guha, M.B.B.S., Ph.D., at Albert Einstein College of Medicine have received a five-year, $2.6 million NIH grant to make immunotherapy agents that are more precise and effective at treating various types of cancers.

Original Article: Researchers at Albert Einstein College of Medicine receive $2.6 million NIH grant to develop targeted cancer immunotherapies

NEXT ARTICLE

More From BioPortfolio on "Researchers at Albert Einstein College of Medicine receive $2.6 million NIH grant to develop targeted cancer immunotherapies"

Quick Search
Advertisement
 

Relevant Topic

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...